AXA Mansard Health’s International Healthcare Plan, iMED, offers Nigerians access to comprehensive medical coverage for cancer, as well as critical medical procedures such as organ and bone marrow transplants, and international emergency medical assistance at leading healthcare facilities in Nigeria, the United States, the United Kingdom and Dubai.
According to estimates by the Global Cancer Observatory (GLOBOCAN), more than 150,000 new cancer cases are diagnosed annually in Nigeria, with over 90,000 deaths recorded each year. Among men, prostate, colorectal and liver cancers remain the most commonly diagnosed, while breast, cervical and colorectal cancers account for the highest incidence among women.
In response to these evolving healthcare needs, AXA Mansard was designed to provide its eligible enrollees with access to premium international health insurance coverage that supports access to advanced medical care for eligible medical conditions through a network of accredited local and international healthcare providers. This product offers comprehensive cover for a broad range of medical services, including chronic condition management, chemotherapy and radiotherapy where medically necessary, helping individuals prepare for unexpected health events and associated medical expenses.
Speaking on the rationale behind the introduction of the plan, Tope Adeniyi, chief executive officer, AXA Mansard Health, said the company remains committed to developing solutions that address evolving healthcare needs while reducing barriers to…
Source link
Read Full Article by Modestus Anaesoronye at businessday.ng
Source link
